NCT01017757|Unknown
Interstitial Lung Abnormalities in Renal Transplant Recipients
LCRT
Cross-sectional Analysis of Subclinical Interstitial Lung Abnormalities in Stable Renal Transplant Recipients by High-resolution CT Scan
Loading search results
LCRT
Cross-sectional Analysis of Subclinical Interstitial Lung Abnormalities in Stable Renal Transplant Recipients by High-resolution CT Scan
Sponsor study identifier
observational
63
1 country
1
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2007
Actual (reported)Study Completion
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Immunosuppressive drugs such as tacrolimus, cyclosporine, mycophenolate mofetil, sirolimus and everolimus may have toxic pulmonary effects, particularly interstitial alterations. The aim of the present study is to explore the presence of subclinical interstitial lung abnormalities in stable renal transplant recipients taking the different immunosuppressive drugs used as maintenance therapy for renal transplantation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
October 2007
Actual (reported)November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 18, 2009
Actual (reported)November 23, 2009
Actual (reported)Subclinical lung alterations as assessed by high-resolution CT scanning
CT is performed at study entry and, if abnormalities are found, it is repeated at 3-6 months
High-resolution CT scanning
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Kidney or kidney-pancreas recipients, on immunosuppressive therapy for at least 24 months
Department of Clinical Medicine Nephrology and Health Science, Parma University Hospital
Parma, Parma, 43100, Italy
Carlo Buzio, MD
University of Parma
63 participants (actual enrollment reported by the registry).
First Submitted
November 18, 2009
First Posted
November 23, 2009
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
October 2007
Actual (reported)Study Completion
November 2009
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 23, 2009
Record last verified: 2009-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: